Skip to main content
SpringerLink
Log in

Achievements in CKD-MBD guidelines targets: is there a progress in the implementation practice?

  • Nephrology - Original Paper
  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

Abstract

Background

Guidelines should help the practicing nephrologists to reduce the variability in diagnostic and treatment strategies, and achieve the best possible patients’ outcomes. The aim of our study was to look at the treatment strategies and the shortcomings in the implementation of the chronic kidney disease mineral and bone disorder (CKD-MBD) KDOQI guidelines in dialysis units across the Republic of Macedonia in 2009, and to analyze trends with regard to our previous analysis from 2005.

Methods

A questionnaire was sent in 2009 to all dialysis units in our country for data concerning CKD-MBD in dialysis patients. This study included 742 patients, comparable with the reply we got on the same our 2005 survey, with a total of 588 patients. We collected the last 6 months mean values of biochemical parameters [calcium (Ca), phosphate (P), and intact parathyroid hormone (iPTH)], as well as treatment data including dialysate Ca concentration, phosphate binding agents, and vitamin D doses.

Results

The majority of patients in both surveys had values within the target ranges for all parameters, except for iPTH, which was <150 pg/ml in most patients, in both reports. Compared to the 2005 study, in 2009 we found a significantly improved control of all four biochemical parameters, but a greater proportion of patients within guidelines targets was found only for serum Ca (79 vs. 67.4%, P < 0.05). Treatment with low Ca dialysate concentration of 1.25 mmol/L continued to be an underused option (3.7 vs. 6.1%), while the 1.75 mmol/L was still the standard dialysate in the majority of patients (57.7 vs. 64.2%). The dose of calcium carbonate was significantly reduced (2.77 ± 1.71 vs. 3.06 ± 1.54, P < 0.01) in 2009 compared to 2005. The mean of the achieved targets increased significantly in 2009 (2.33 ± 1.05 vs. 2.13 ± 1.03, P < 0.01).

Conclusion

There was an improved control of all bone and mineral parameters in our dialysis units, following the publication of the CKD-MBD KDOQI guidelines. In order to improve the iPTH values, a more frequent use of low Ca dialysate (1.25 mmol/L) and of non-calcium-based phosphate binders in this small subset of patients should be implemented, as recommended by the guidelines. Individualization of the CKD-MBD management may be successful, even when newer treatment options are not available. Finally, the guidelines implementation process should be a continuous and self-monitored process, with the help of periodic surveys.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Levin N, Eknoyan G, Pipp M, Steinberg E (1997) National Kidney Foundation: dialysis outcome quality initiative-development of methodology for clinical practice guidelines. Nephrol Dial Transplant 12:2060–2063

    Article  PubMed  CAS  Google Scholar 

  2. Moe S, Drueke T, Cunningham J et al (2006) Kidney disease: improving global outcomes (KDIGO). Definition, evaluation, and classification of renal osteodystrophy: a position statement from kidney disease: improving global outcomes (KDIGO). Kidney Int 69:1945–1953

    Article  PubMed  CAS  Google Scholar 

  3. Spasovski G, Massy Z, Vanholder R (2009) Phosphate metabolism in chronic kidney disease: from pathophysiology to clinical management. Semin Dial 22(4):357–362

    Article  PubMed  Google Scholar 

  4. Kestenbaum B, Sampson JN, Rudser KD et al (2005) Serum phosphate levels and mortality risk among people with chronic kidney disease. J Am Soc Nephrol 16:520–528

    Article  PubMed  CAS  Google Scholar 

  5. Tentori F, Blayney MJ, Albert JM et al (2008) Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the dialysis outcomes and practice patterns study (DOPPS). Am J Kidney Dis 52:519–530

    Article  PubMed  CAS  Google Scholar 

  6. National Kidney Foundation (2003) K/DOQI, NKF: clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 42:S1–S201

    Google Scholar 

  7. Zoccali C, Abramowicz D, Cannata-Andia JB et al (2008) European best practice quo vadis? From European best practice guidelines (EBPG) to European renal best practice (ERBP). Nephrol Dial Transplant 23:2162–2166

    Article  PubMed  Google Scholar 

  8. Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group (2009) KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Kidney Int Suppl 113:S1–S130

    Google Scholar 

  9. Goldsmith DJ, Covic A, Fouque D, Locatelli F, Olgaard K, Rodriguez M, Spasovski G, Urena P, Zoccali C, London GM, Vanholder R (2010) Endorsement of the kidney disease improving global outcomes (KDIGO) chronic kidney disease-mineral and bone disorder (CKD-MBD) guidelines: a European renal best practice (ERBP) commentary statement. Nephrol Dial Transplant 25(12):3823–3831

    Article  PubMed  Google Scholar 

  10. Spasovski G (2009) Treatment of hyperphosphataemia and relationship with the KDOQI CKD-MBD guidelines. Port J Nephrol Hypert 23(4):293–297. https://www.spnefro.pt/RPNH/PDFs/n4_2009/artigo_01.pdf

    Google Scholar 

  11. Spasovski G, Polenakovic M (2008) Renal best practice guidance/guidelines and implementation controversy. BANTAO J 6(2):1–2. http://www.bantao.org/6_2/6_2_1.pdf

    Google Scholar 

  12. Spasovski G, Gelev S, Zdravkovska V, Tomanovski V, Trpenovski L, Ivanovski K, Bajraktarova T, Janakievska P, Damjanovski M, Neskovski J, Karceva-Sarajlia E, Petrovska T, Filkovska K, Matovic S, Luseva V, Jordanovski D, Zafirovska M (2005) Epidemiology of renal osteodystrophy in R. Macedonia. Bantao J 3(2):160–161. http://www.bantao.org/3_2/3_2_50.pdf

    Google Scholar 

  13. Stojceva-Taneva O (2010) Epidemiology of renal replacement therapy in Macedonia. Bosn J Basic Med Sci 10(Suppl 1):S23–S28

    PubMed  Google Scholar 

  14. Spasovski G (2011) Can we decrease organ trafficking in the Balkans? Clin Transplant 25(3):E223–E224

    Article  PubMed  Google Scholar 

  15. Spasovski GB (2007) Bone health and vascular calcification relationships in chronic kidney disease. Int Urol Nephrol 39(4):1209–1216

    Article  PubMed  CAS  Google Scholar 

  16. London GM, Marty C, Marchais SJ et al (2004) Arterial calcifications and bone histomorphometry in end-stage renal disease. J Am Soc Nephrol 15:1943–1951

    Article  PubMed  Google Scholar 

  17. Jean G, Lataillade D, Genet L, Legrand E et al (2011) Association between very low PTH levels and poor survival rates in haemodialysis patients: results from the French ARNOS cohort. Nephron Clin Pract 118(2):c211–c216

    Article  PubMed  CAS  Google Scholar 

  18. Spasovski G (2011) A review of Sevelamer hydrochloride in end-stage renal disease patients on dialysis. Clin Med Insights Ther 3:51–55. http://www.la-press.com/clinical-medicine-insights-therapeutics-journal-j133

    Google Scholar 

  19. Spasovski G (2008) New strategies in treatment of mineral and bone disorders and associated cardiovascular disease in patients with chronic kidney disease. Recent Pat Cardiovasc Drug Discov 3(3):222–228

    Article  PubMed  CAS  Google Scholar 

  20. Spasovski G, Gelev S, Masin-Spasovska J, Selim G, Sikole A, Vanholder R (2007) Improvement of bone and mineral parameters related to adynamic bone disease by diminishing dialysate calcium. Bone 41(4):698–703

    Article  PubMed  CAS  Google Scholar 

  21. Matias PJ, Jorge C, Ferreira C et al (2010) Cholecalciferol supplementation in hemodialysis patients: effects on mineral metabolism, inflammation, and cardiac dimension parameters. Clin J Am Soc Nephrol 5:905–911

    Article  PubMed  CAS  Google Scholar 

  22. Wald R, Tentori F, Tighiouart H, Zager PG, Miskulin DC (2007) Impact of the kidney disease outcomes quality initiative (KDOQI) clinical practice guidelines for bone metabolism and disease in a large dialysis network. Am J Kidney Dis 49(2):257–266

    Article  PubMed  CAS  Google Scholar 

  23. Tangri N, Wagner M, Griffith JL et al (2011) Effect of bone mineral guideline target achievement on mortality in incident dialysis patients: an analysis of the United Kingdom renal registry. Am J Kidney Dis 57(3):415–421

    Article  PubMed  Google Scholar 

  24. Arenas MD, Alvarez-Ude F, Gil MT et al (2006) Application of NKF-K/DOQI clinical practice guidelines for bone metabolism and disease: changes of clinical practices and their effects on outcomes and quality standards in three haemodialysis units. Nephrol Dial Transplant 21:1663–1668

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

The authors wish to express their thanks for the partial logistic support in data collection by the Genzyme company.

Conflict of interest

None.

Author information

Authors and Affiliations

  1. Department of Nephrology, Medical Faculty, University of Skopje, Vodnjanska 17, 1000, Skopje, Republic of Macedonia

    G. Spasovski, J. Masin-Spasovska & S. Gelev

  2. Dialysis Unit, Zelezara, Skopje, Republic of Macedonia

    V. Zdravkovska

  3. Dialysis Unit, Struga, Republic of Macedonia

    M. Zabzun & N. Taleska-Matovska

  4. Dialysis Unit, Military Hospital Skopje, Skopje, Republic of Macedonia

    R. Antarorov

  5. Dialysis Unit, Kumanovo, Republic of Macedonia

    K. Ivanovski

  6. Dialysis Unit, Bitola, Republic of Macedonia

    P. Janakievska

  7. Dialysis Unit, Gostivar, Republic of Macedonia

    J. Neskovski

  8. Dialysis Unit, Strumica, Republic of Macedonia

    E. Karceva-Sarajlia

  9. Dialysis Unit, Kocani, Republic of Macedonia

    B. Panova

  10. Dialysis Unit, Delcevo, Republic of Macedonia

    T. Petrovska

  11. Dialysis Unit, Tetovo, Republic of Macedonia

    L. Zulbeari

Authors
  1. G. Spasovski
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. V. Zdravkovska
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. Zabzun
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. R. Antarorov
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. K. Ivanovski
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. P. Janakievska
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. J. Neskovski
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. E. Karceva-Sarajlia
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. B. Panova
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. T. Petrovska
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. L. Zulbeari
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. J. Masin-Spasovska
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. N. Taleska-Matovska
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. S. Gelev
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to G. Spasovski.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Spasovski, G., Zdravkovska, V., Zabzun, M. et al. Achievements in CKD-MBD guidelines targets: is there a progress in the implementation practice?. Int Urol Nephrol 44, 1791–1798 (2012). https://doi.org/10.1007/s11255-011-0092-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11255-011-0092-x

Keywords

Search

Navigation